Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients

Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC pulmonary medicine 2015-09, Vol.15 (1), p.107-107, Article 107
Hauptverfasser: Schnabel, R M, van der Velden, K, Osinski, A, Rohde, G, Roekaerts, P M H J, Bergmans, D C J J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 107
container_issue 1
container_start_page 107
container_title BMC pulmonary medicine
container_volume 15
creator Schnabel, R M
van der Velden, K
Osinski, A
Rohde, G
Roekaerts, P M H J
Bergmans, D C J J
description Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h. Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression. a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p < 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of >25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death. Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.
doi_str_mv 10.1186/s12890-015-0104-1
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4588466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541424754</galeid><sourcerecordid>A541424754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</originalsourceid><addsrcrecordid>eNptUk1rFTEUDWKxtfoD3EjATTfT5nOS2QjlYVUouNF1yGTuzItkkmcy70l3_nQzvGdpQULIzc05557AQegdJdeU6vamUKY70hAq6yaioS_QBRWKNky07csn9Tl6XcpPQqjSkr9C56wVjHDOL9CfTfDROxuwS_tcANs41HLehdpcfIoFjymE9NvHCQ_eTjGVxTvc5xTdNtlwgBRsxsEe7ATYR-yyX1bB8IB9CHgGt7Xx1DhAXHywCwx4V9XrrbxBZ6MNBd6ezkv04-7T982X5v7b56-b2_vGVf9LwyTrZM87MZIBnKDC0VZZwjS3ShDBlOtAaNE7QVo19LoHoLbtmGql1Gxk_BJ9POru9v0Mg6uzsw1ml_1s84NJ1pvnL9FvzZQORkitq4UqcHUSyOnXHspiZl8chGAjpH0xVFHNORFyhX44QicbwPg4pqroVri5ldU7E0qKirr-D6quAWbvUoTR1_4zAj0SXE6lZBgf3VNi1kCYYyBMDYRZA2Fo5bx_-u1Hxr8E8L8J67NZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1718330456</pqid></control><display><type>article</type><title>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>TestCollectionTL3OpenAccess</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Schnabel, R M ; van der Velden, K ; Osinski, A ; Rohde, G ; Roekaerts, P M H J ; Bergmans, D C J J</creator><creatorcontrib>Schnabel, R M ; van der Velden, K ; Osinski, A ; Rohde, G ; Roekaerts, P M H J ; Bergmans, D C J J</creatorcontrib><description>Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h. Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression. a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p &lt; 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of &gt;25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death. Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.</description><identifier>ISSN: 1471-2466</identifier><identifier>EISSN: 1471-2466</identifier><identifier>DOI: 10.1186/s12890-015-0104-1</identifier><identifier>PMID: 26420333</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Aged ; Anti-Bacterial Agents - therapeutic use ; Arrhythmias, Cardiac - epidemiology ; Bacteremia - epidemiology ; Bacterial pneumonia ; Bronchoalveolar Lavage ; Bronchoscopy ; Care and treatment ; Comparative analysis ; Complications and side effects ; Critical Illness ; Diagnosis ; Escherichia coli ; Escherichia coli Infections - diagnosis ; Escherichia coli Infections - drug therapy ; Female ; Health aspects ; Hemoptysis - epidemiology ; Hospital Mortality ; Humans ; Hypertension - epidemiology ; Hypoxia - epidemiology ; Logistic Models ; Male ; Medical research ; Medicine, Experimental ; Middle Aged ; Patient outcomes ; Pneumonia ; Pneumonia, Staphylococcal - diagnosis ; Pneumonia, Staphylococcal - drug therapy ; Pneumonia, Ventilator-Associated - diagnosis ; Pneumonia, Ventilator-Associated - drug therapy ; Pneumonia, Ventilator-Associated - microbiology ; Pneumothorax - epidemiology ; Postoperative Complications - epidemiology ; Pseudomonas aeruginosa ; Pseudomonas Infections - diagnosis ; Pseudomonas Infections - drug therapy ; Respiration, Artificial ; Staphylococcus aureus</subject><ispartof>BMC pulmonary medicine, 2015-09, Vol.15 (1), p.107-107, Article 107</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Schnabel et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</citedby><cites>FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588466/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588466/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26420333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schnabel, R M</creatorcontrib><creatorcontrib>van der Velden, K</creatorcontrib><creatorcontrib>Osinski, A</creatorcontrib><creatorcontrib>Rohde, G</creatorcontrib><creatorcontrib>Roekaerts, P M H J</creatorcontrib><creatorcontrib>Bergmans, D C J J</creatorcontrib><title>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</title><title>BMC pulmonary medicine</title><addtitle>BMC Pulm Med</addtitle><description>Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h. Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression. a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p &lt; 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of &gt;25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death. Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.</description><subject>Aged</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Arrhythmias, Cardiac - epidemiology</subject><subject>Bacteremia - epidemiology</subject><subject>Bacterial pneumonia</subject><subject>Bronchoalveolar Lavage</subject><subject>Bronchoscopy</subject><subject>Care and treatment</subject><subject>Comparative analysis</subject><subject>Complications and side effects</subject><subject>Critical Illness</subject><subject>Diagnosis</subject><subject>Escherichia coli</subject><subject>Escherichia coli Infections - diagnosis</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hemoptysis - epidemiology</subject><subject>Hospital Mortality</subject><subject>Humans</subject><subject>Hypertension - epidemiology</subject><subject>Hypoxia - epidemiology</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Patient outcomes</subject><subject>Pneumonia</subject><subject>Pneumonia, Staphylococcal - diagnosis</subject><subject>Pneumonia, Staphylococcal - drug therapy</subject><subject>Pneumonia, Ventilator-Associated - diagnosis</subject><subject>Pneumonia, Ventilator-Associated - drug therapy</subject><subject>Pneumonia, Ventilator-Associated - microbiology</subject><subject>Pneumothorax - epidemiology</subject><subject>Postoperative Complications - epidemiology</subject><subject>Pseudomonas aeruginosa</subject><subject>Pseudomonas Infections - diagnosis</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Respiration, Artificial</subject><subject>Staphylococcus aureus</subject><issn>1471-2466</issn><issn>1471-2466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptUk1rFTEUDWKxtfoD3EjATTfT5nOS2QjlYVUouNF1yGTuzItkkmcy70l3_nQzvGdpQULIzc05557AQegdJdeU6vamUKY70hAq6yaioS_QBRWKNky07csn9Tl6XcpPQqjSkr9C56wVjHDOL9CfTfDROxuwS_tcANs41HLehdpcfIoFjymE9NvHCQ_eTjGVxTvc5xTdNtlwgBRsxsEe7ATYR-yyX1bB8IB9CHgGt7Xx1DhAXHywCwx4V9XrrbxBZ6MNBd6ezkv04-7T982X5v7b56-b2_vGVf9LwyTrZM87MZIBnKDC0VZZwjS3ShDBlOtAaNE7QVo19LoHoLbtmGql1Gxk_BJ9POru9v0Mg6uzsw1ml_1s84NJ1pvnL9FvzZQORkitq4UqcHUSyOnXHspiZl8chGAjpH0xVFHNORFyhX44QicbwPg4pqroVri5ldU7E0qKirr-D6quAWbvUoTR1_4zAj0SXE6lZBgf3VNi1kCYYyBMDYRZA2Fo5bx_-u1Hxr8E8L8J67NZ</recordid><startdate>20150929</startdate><enddate>20150929</enddate><creator>Schnabel, R M</creator><creator>van der Velden, K</creator><creator>Osinski, A</creator><creator>Rohde, G</creator><creator>Roekaerts, P M H J</creator><creator>Bergmans, D C J J</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150929</creationdate><title>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</title><author>Schnabel, R M ; van der Velden, K ; Osinski, A ; Rohde, G ; Roekaerts, P M H J ; Bergmans, D C J J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-25295b394f0dec414c167a0283a740427c9e484bc4067db8bee1a692765582f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Arrhythmias, Cardiac - epidemiology</topic><topic>Bacteremia - epidemiology</topic><topic>Bacterial pneumonia</topic><topic>Bronchoalveolar Lavage</topic><topic>Bronchoscopy</topic><topic>Care and treatment</topic><topic>Comparative analysis</topic><topic>Complications and side effects</topic><topic>Critical Illness</topic><topic>Diagnosis</topic><topic>Escherichia coli</topic><topic>Escherichia coli Infections - diagnosis</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hemoptysis - epidemiology</topic><topic>Hospital Mortality</topic><topic>Humans</topic><topic>Hypertension - epidemiology</topic><topic>Hypoxia - epidemiology</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Patient outcomes</topic><topic>Pneumonia</topic><topic>Pneumonia, Staphylococcal - diagnosis</topic><topic>Pneumonia, Staphylococcal - drug therapy</topic><topic>Pneumonia, Ventilator-Associated - diagnosis</topic><topic>Pneumonia, Ventilator-Associated - drug therapy</topic><topic>Pneumonia, Ventilator-Associated - microbiology</topic><topic>Pneumothorax - epidemiology</topic><topic>Postoperative Complications - epidemiology</topic><topic>Pseudomonas aeruginosa</topic><topic>Pseudomonas Infections - diagnosis</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Respiration, Artificial</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schnabel, R M</creatorcontrib><creatorcontrib>van der Velden, K</creatorcontrib><creatorcontrib>Osinski, A</creatorcontrib><creatorcontrib>Rohde, G</creatorcontrib><creatorcontrib>Roekaerts, P M H J</creatorcontrib><creatorcontrib>Bergmans, D C J J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC pulmonary medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schnabel, R M</au><au>van der Velden, K</au><au>Osinski, A</au><au>Rohde, G</au><au>Roekaerts, P M H J</au><au>Bergmans, D C J J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients</atitle><jtitle>BMC pulmonary medicine</jtitle><addtitle>BMC Pulm Med</addtitle><date>2015-09-29</date><risdate>2015</risdate><volume>15</volume><issue>1</issue><spage>107</spage><epage>107</epage><pages>107-107</pages><artnum>107</artnum><issn>1471-2466</issn><eissn>1471-2466</eissn><abstract>Flexible, fibreoptic bronchoscopy (FFB) and bronchoalveolar lavage (BAL) have been used for diagnostic purposes in critically ill ventilated patients. The additional diagnostic value compared to tracheal aspirations in ventilator-associated pneumonia (VAP) has been questioned. Nevertheless, BAL can provide extra information for the differential diagnosis of respiratory disease and good antibiotic stewardship. These benefits should outweigh potential hazards caused by the invasiveness of this diagnostic technique. The focus of the present study was on the clinical course and complications of patients following BAL procedures up to 24 h. Hundred sixty-four FFB guided BAL procedures for suspected pneumonia were analysed in an observational study. The clinical course of patients was monitored by respiratory and haemodynamic data before BAL, 1 and 24 h after BAL. Complications were defined and registered. Factors associated with complications were analysed by logistic regression. a decrease in average pO2/FiO2 ratio 1 h after BAL from 29 kPa (218 mmHg) to 25 kPa (189 mmHg) (p &lt; 0.05) was observed which fully recovered within 24 h. Respiratory complications: the incidence of procedure related hypo-oxygenation (SaO2 ≤ 88 %) and/or bronchospasm was 9 %; a decrease of &gt;25 % PaO2/FiO2 ratio 1 h after BAL was found in 29 % of patients; no bleeding or pneumothorax were registered. Haemodynamic complications: there were no cases of hypertension and cardiac rhythm disturbances; haemodynamic instability within the first 24 h after BAL was recorded in 22 %; this was correlated with a cardiovascular diagnosis at admission (OR 2.9; 95 % CI 1.2 - 6.7) and the presence of cardiovascular co-morbidity (OR 3.5; 95 % CI 1.5 - 8.3). The incidence of bacteraemia was 7 %. There was no case of procedure related death. Frequently occurring haemodynamic and respiratory instability but no cases of cardiac rhythm disturbances, bleeding, pneumothorax or procedure related death were attributable to diagnostic FFB and BAL. The procedures should be conducted under careful supervision by experienced physicians. Only a randomized controlled trial that compares diagnostic FFB and BAL with a non-invasive strategy could ultimately establish the safety profile and clinical utility of these procedures in critically ill ventilated patients.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26420333</pmid><doi>10.1186/s12890-015-0104-1</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2466
ispartof BMC pulmonary medicine, 2015-09, Vol.15 (1), p.107-107, Article 107
issn 1471-2466
1471-2466
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4588466
source MEDLINE; Springer Nature - Complete Springer Journals; TestCollectionTL3OpenAccess; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Aged
Anti-Bacterial Agents - therapeutic use
Arrhythmias, Cardiac - epidemiology
Bacteremia - epidemiology
Bacterial pneumonia
Bronchoalveolar Lavage
Bronchoscopy
Care and treatment
Comparative analysis
Complications and side effects
Critical Illness
Diagnosis
Escherichia coli
Escherichia coli Infections - diagnosis
Escherichia coli Infections - drug therapy
Female
Health aspects
Hemoptysis - epidemiology
Hospital Mortality
Humans
Hypertension - epidemiology
Hypoxia - epidemiology
Logistic Models
Male
Medical research
Medicine, Experimental
Middle Aged
Patient outcomes
Pneumonia
Pneumonia, Staphylococcal - diagnosis
Pneumonia, Staphylococcal - drug therapy
Pneumonia, Ventilator-Associated - diagnosis
Pneumonia, Ventilator-Associated - drug therapy
Pneumonia, Ventilator-Associated - microbiology
Pneumothorax - epidemiology
Postoperative Complications - epidemiology
Pseudomonas aeruginosa
Pseudomonas Infections - diagnosis
Pseudomonas Infections - drug therapy
Respiration, Artificial
Staphylococcus aureus
title Clinical course and complications following diagnostic bronchoalveolar lavage in critically ill mechanically ventilated patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T15%3A22%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20course%20and%20complications%20following%20diagnostic%20bronchoalveolar%20lavage%20in%20critically%20ill%20mechanically%20ventilated%20patients&rft.jtitle=BMC%20pulmonary%20medicine&rft.au=Schnabel,%20R%20M&rft.date=2015-09-29&rft.volume=15&rft.issue=1&rft.spage=107&rft.epage=107&rft.pages=107-107&rft.artnum=107&rft.issn=1471-2466&rft.eissn=1471-2466&rft_id=info:doi/10.1186/s12890-015-0104-1&rft_dat=%3Cgale_pubme%3EA541424754%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1718330456&rft_id=info:pmid/26420333&rft_galeid=A541424754&rfr_iscdi=true